Conference Reports for NATAP

The International Liver Congress™ EASL - European Association for the Study of the Liver Barcelona, Spain 13-17 April 2016 Back

Efficacy and Safety of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir Without Ribavirin in Patients with HCV Genotype 1b With or Without Compensated Cirrhosis: Pooled Analysis Across 5 Clinical Trials       Reported by Jules Levin EASL 2016 April 14-17 Barcelona   Tania Welzel et al